These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18214171)

  • 21. Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study.
    Atalell KA; Birhan Tebeje N; Ekubagewargies DT
    PLoS One; 2018; 13(5):e0197145. PubMed ID: 29787596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteriologically confirmed tuberculosis in HIV-infected infants: disease spectrum and survival.
    Wiseman CA; Schaaf HS; Cotton MF; Gie RP; Jennings T; Whitelaw A; Roux P; Hesseling AC
    Int J Tuberc Lung Dis; 2011 Jun; 15(6):770-5. PubMed ID: 21575297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4 count and risk of anti-tuberculosis drug-associated cutaneous reactions in HIV-infected Thai patients.
    Boonyagars L; Hirunwiwatkul P; Hurst CP
    Int J Tuberc Lung Dis; 2017 Mar; 21(3):338-344. PubMed ID: 28225346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of HIV-infected children with tuberculosis who are started on antiretroviral therapy in Malawi.
    Bong CN; Chen SC; Jong YJ; Tok TS; Hsu CF; Schouten EJ; Makombe SD; Yu JK; Harries AD
    Int J Tuberc Lung Dis; 2007 May; 11(5):534-8. PubMed ID: 17439677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuberculosis Treatment Outcomes Among HIV/TB-Coinfected Children in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Network.
    Carlucci JG; Blevins Peratikos M; Kipp AM; Lindegren ML; Du QT; Renner L; Reubenson G; Ssali J; Yotebieng M; Mandalakas AM; Davies MA; Ballif M; Fenner L; Pettit AC;
    J Acquir Immune Defic Syndr; 2017 Jun; 75(2):156-163. PubMed ID: 28234689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes in HIV-infected patients on antiretroviral therapy with tuberculosis.
    Tansuphasawadikul S; Saito W; Kim J; Phonrat B; Dhitavat J; Chamnachanan S; Pitisuttithum P
    Southeast Asian J Trop Med Public Health; 2007 Nov; 38(6):1053-60. PubMed ID: 18613546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa.
    Pepper DJ; Marais S; Wilkinson RJ; Bhaijee F; De Azevedo V; Meintjes G
    PLoS One; 2011 May; 6(5):e19484. PubMed ID: 21589868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation and operational research: Integrated pre-antiretroviral therapy screening and treatment for tuberculosis and cryptococcal antigenemia.
    Pac L; Horwitz MM; Namutebi AM; Auerbach BJ; Semeere A; Namulema T; Schwarz M; Bbosa R; Muruta A; Meya DB; Manabe YC
    J Acquir Immune Defic Syndr; 2015 Apr; 68(5):e69-76. PubMed ID: 25761234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Outcomes in Children With Human Immunodeficiency Virus Treated for Nonsevere Tuberculosis in the SHINE Trial.
    Chabala C; Wobudeya E; van der Zalm MM; Kapasa M; Raichur P; Mboizi R; Palmer M; Kinikar A; Hissar S; Mulenga V; Mave V; Musoke P; Hesseling AC; McIlleron H; Gibb D; Crook A; Turkova A;
    Clin Infect Dis; 2024 Jul; 79(1):70-77. PubMed ID: 38592950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linking HIV-infected TB patients to cotrimoxazole prophylaxis and antiretroviral treatment in India.
    Raizada N; Chauhan LS; Babu BS; Thakur R; Khera A; Wares DF; Sahu S; Bachani D; Rewari BB; Dewan PK
    PLoS One; 2009 Jun; 4(6):e5999. PubMed ID: 19543396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
    Shoko C; Chikobvu D; Bessong PO
    S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting.
    Duncombe C; Kerr SJ; Ruxrungtham K; Dore GJ; Law MG; Emery S; Lange JM; Phanuphak P; Cooper DA
    AIDS; 2005 Jan; 19(2):169-78. PubMed ID: 15668542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral hepatitis and HIV-associated tuberculosis: risk factors and TB treatment outcomes in Thailand.
    Sirinak C; Kittikraisak W; Pinjeesekikul D; Charusuntonsri P; Luanloed P; Srisuwanvilai LO; Nateniyom S; Akksilp S; Likanonsakul S; Sattayawuthipong W; Burapat C; Varma JK
    BMC Public Health; 2008 Jul; 8():245. PubMed ID: 18638392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of integrating HIV and TB care and treatment in a regional tuberculosis hospital in rural Guatemala.
    Ikeda JM; Tellez CA; Hudes ES; Page K; Evans J; Racancoj O; Hearst N
    AIDS Behav; 2014 Jan; 18 Suppl 1():S96-103. PubMed ID: 23959143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment outcomes of patients co-infected with tuberculosis and HIV at Chiang Mai University Hospital, Thailand.
    Limmahakhun S; Chaiwarith R; Nuntachit N; Sirisanthana T; Supparatpinyo K
    Int J STD AIDS; 2012 Jun; 23(6):414-8. PubMed ID: 22807535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The shift in tuberculosis timing among people living with HIV in the course of antiretroviral therapy scale-up in Malawi.
    Tweya H; Feldacker C; Mpunga J; Kanyerere H; Heller T; Ganesh P; Nkosi D; Kalulu M; Sinkala G; Satumba T; Phiri S
    J Int AIDS Soc; 2019 Apr; 22(4):e25240. PubMed ID: 31038836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second-Line Antiretroviral Treatment Outcome in HIV-Infected Patients Coinfected with Tuberculosis in Pakistan.
    Shafiq M; Zafar S; Ahmad A; Kazmi A; Fatima A; Mujahid TA; Qazi R; Akhter N; Shahzad A; Rehman SU; Shereen MA; Hyder MZ
    Biomed Res Int; 2023; 2023():4187488. PubMed ID: 37124927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review.
    Arentz M; Pavlinac P; Kimerling ME; Horne DJ; Falzon D; Schünemann HJ; Royce S; Dheda K; Walson JL;
    PLoS One; 2012; 7(11):e47370. PubMed ID: 23144818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport.
    Zachariah R; Harries AD; Manzi M; Gomani P; Teck R; Phillips M; Firmenich P
    PLoS One; 2006 Dec; 1(1):e121. PubMed ID: 17205125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of TB/HIV Integration on TB and HIV Indicators in Rural Ugandan Health Facilities.
    Burnett SM; Zawedde-Muyanja S; Hermans SM; Weaver MR; Colebunders R; Manabe YC
    J Acquir Immune Defic Syndr; 2018 Dec; 79(5):605-611. PubMed ID: 30383587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.